Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Colour vision restrictions for driving: an evidence-based perspective on regulations in ASEAN countries compared to other countries.
Tan TF, Wongsawad W, Hurairah H, Loy MJ, Lwin WW, Mohd Rawi NA, Sidik M, Grzybowski A, Raman R, Ruamviboonsuk P, Tan ACS. Tan TF, et al. Among authors: ruamviboonsuk p. Lancet Reg Health Southeast Asia. 2023 Mar 3;14:100171. doi: 10.1016/j.lansea.2023.100171. eCollection 2023 Jul. Lancet Reg Health Southeast Asia. 2023. PMID: 37492411 Free PMC article. Review.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Among authors: ruamviboonsuk p. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand.
Dilokthornsakul P, Chaiyakunapruk N, Ruamviboonsuk P, Ratanasukon M, Ausayakhun S, Tungsomeroengwong A, Pokawattana N, Chanatittarat C. Dilokthornsakul P, et al. Among authors: ruamviboonsuk p. Int J Ophthalmol. 2014 Feb 18;7(1):145-51. doi: 10.3980/j.issn.2222-3959.2014.01.27. eCollection 2014. Int J Ophthalmol. 2014. PMID: 24634881 Free PMC article.
International Classification System for Ocular Complications of Anti-VEGF Agents in Clinical Trials.
Popovic MM, Balas M, Sadda SR, Sarraf D, Huang R, Bakri SJ, Berrocal A, Chang A, Gemmy Cheung CM, Garg S, Hillier RJ, Holz FG, Johnson MW, Kaiser PK, Kertes PJ, Lai TYY, Noble J, Park SS, Paulus YM, Querques G, Rachitskaya A, Ruamviboonsuk P, Saidkasimova S, Sandinha MT, Steel DH, Terasaki H, Weng CY, Williams BK Jr, Wu L, Muni RH. Popovic MM, et al. Among authors: ruamviboonsuk p. Ophthalmology. 2024 Dec;131(12):1457-1467. doi: 10.1016/j.ophtha.2024.06.011. Epub 2024 Jun 13. Ophthalmology. 2024. PMID: 38878904 Free article.
Predicting optical coherence tomography-derived diabetic macular edema grades from fundus photographs using deep learning.
Varadarajan AV, Bavishi P, Ruamviboonsuk P, Chotcomwongse P, Venugopalan S, Narayanaswamy A, Cuadros J, Kanai K, Bresnick G, Tadarati M, Silpa-Archa S, Limwattanayingyong J, Nganthavee V, Ledsam JR, Keane PA, Corrado GS, Peng L, Webster DR. Varadarajan AV, et al. Among authors: ruamviboonsuk p. Nat Commun. 2020 Jan 8;11(1):130. doi: 10.1038/s41467-019-13922-8. Nat Commun. 2020. PMID: 31913272 Free PMC article. Clinical Trial.
Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis.
Campbell JP, Chiang MF, Chen JS, Moshfeghi DM, Nudleman E, Ruambivoonsuk P, Cherwek H, Cheung CY, Singh P, Kalpathy-Cramer J, Ostmo S, Eydelman M, Chan RVP, Capone A Jr; Collaborative Community in Ophthalmic Imaging Executive Committee and the Collaborative Community in Ophthalmic Imaging Retinopathy of Prematurity Workgroup. Campbell JP, et al. Ophthalmology. 2022 Jul;129(7):e69-e76. doi: 10.1016/j.ophtha.2022.02.008. Epub 2022 Feb 12. Ophthalmology. 2022. PMID: 35157950 Free PMC article.
97 results